U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Icon_funbox Did You Know...

...that to encourage use of his new invention, the shopping cart, market owner Sylvan Goldman hired fake shoppers to push the carts around his store in Oklahoma City? Seems his customers were reluctant to give up their hand-carried baskets.

Newsletter  PatentStorm News

Make the Most of Our Site

See this month's Top Inventors and Most Cited Patents.

Stay on top of the latest innovations by subscribing to an RSS feed.

Registered users: Manage your profile.

 

Class 560/159 - Additional nitrogen in acid moiety


Subclass of Class 560 - Organic compounds -- part of the class 532-570 series
Definition: Compounds wherein the acid radical contains covalently bonded
No. of patents: 282
Last issue date: 11/03/2009


1                
NumberTitleIssue Date
7612226Amino acid derivatives
The present invention relates to a method of treating pain using a compound of formula wherein R1, R2, R3 and R4 are as defined herein. The invention also relates to certain novel...
11/03/2009
7351852T-butoxycarbonylaminoethylamine for the synthesis of PNA monomer units, amino acid derivatives, intermediates therof, and processes for productions of them
A process for amino acid derivatives shown by the below general formula (I): (wherein R1 means a hydrogen atom or a straight chain or branched chain alkyl group with 1-5 carbon atoms.) having an object to provide...
04/01/2008
7282575Functional peptide nucleic acid monomer and process for producing the same
A compound represented by the general formula (I) below: In the formula, A is as defined in the specification and B denotes where n is an integer of 1 to 4, ...
10/16/2007
7238834Piperidine derivatives and process for their production
The present invention relates to substantially pure piperidine derivative compounds of the formulae: wherein R1 is hydrogen or hydroxy; R2
07/03/2007
7202236Modified release pharmaceutical formulation
A modified release pharmaceutical composition comprising, as active ingredient, a compound of formula (I), wherein R1 represents C?1-2#191 alkyl substituted by one or more fluoro substituents; R2 represents hydrogen, hydroxy, methoxy or ethoxy;...
04/10/2007
7189879Process for the production of 1-hydroxymethyl-1,3,5-triazapentane, trihydrochloride
A new process for the production of 1-hydroxymethyl-1,3,5-triazapentane, trihydrochloride is described. ...
03/13/2007
7157596Inhibitors of serine protease activity of matriptase or MTSP1
The present invention provides compounds which inhibit serine protease activity of matriptase or MTSP1. Also provided are pharmaceutical compositions comprising those compounds and methods of using the compounds and pharmaceutical compositions to treat conditions am...
01/02/2007
7129233Mandelic acid derivatives and their use as thrombin inhibitors
There is provided a compound of formula I wherein Ra, R1, R2, Y and R3 have meanings given in the description and pharmaceutically-acceptable derivatives (including pro...
10/31/2006
7038084Succinoylamino hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
Succinoylamino hydroxyethylamino sulfonamide compounds are effective as retroviral protease inhibitors, and in particular as inhibitors of HIV protease. ...
05/02/2006
7026515Optically active amine derivatives and preparation process therefor
A readily available and inexpensive natural α-amino acid is converted into a compound represented by formula (1), which is then reacted with an organometallic reagent represented by formula (2) to give an optically active 5-hydroxyoxazolidine represented by formula...
04/11/2006
6984626Gamma-secretase inhibitors
A class of compounds is disclosed which are diasteroisomers of a known class of protease inhibitors. The compound inhibit gamma-secretase, and find use in the treatment of and/or prevention of Alzheimer's disease. ...
01/10/2006
6919476T-butoxycarbonylaminoethylamine for the synthesis of PNA monomer units, amino acid derivatives, intermediates thereof, and processes for productions of them
A process for amino acid derivatives shown by the below general formula (I): (wherein R1 means a hydrogen atom or a straight chain or branched chain alkyl group with 1-5 carbon atoms.) having an object to pr...
07/19/2005
6906092Method of inhibiting matrix metalloproteinases
The present invention relates to a method of inhibiting matrix metalloproteinases using compounds that are dibenzofuran sulfonamide derivatives having the Formula I More particularly, the present invention relates to a m...
06/14/2005
6872847Process for the preparation of alkyl-n-(3-dimethylamino) alkylcarbamates
This invention relates to a process for the preparation of alkyl-N-(3-dimethylamino)alkylcarbamates by reacting an alkyl-chloroformate in an alcohol. ...
03/29/2005
6858414Multistage process for the preparation of highly pure deferoxamine mesylate salt
The present invention provides a purification process whereby deferoxamine B produced by a microorganism and in mixture with other polyhydroxamates produced by the microorganism may be converted into its mesylate salt substantially free of the other polyhydroxamates...
02/22/2005
6803383Inhibition of angiogenesis and tumor growth
Compounds which inhibit tumor growth and angiogenesis, of general formula (II) are provided. These compounds include glycyl lysine derivatives bound to a central aromatic linking core. ...
10/12/2004
6777443Dipeptide derivatives
Compounds of the formula wherein R, R1, COOR2, R3-R7, alk, and X have meaning as defined, such being useful as dual inhibitors of angiotensin converting enzyme and neutral endo...
08/17/2004
6740741Diazo derivatives and process for their preparation
Novel diazo derivatives useful for the deacidification of paper material and the process for their preparation comprising three steps starting from an amine and ethyl chlorocarbonate, are described. ...
05/25/2004
6720306Tetrapartate prodrugs
A compound of Formula I, providing tetrapartate prodrugs is provided wherein: L1 is a bifunctional linking moiety; D is a moiety that is a leaving group, or a residue of a compound to be delivere...
04/13/2004
6710085Methods for enhancing plant growth using diacyl ureas
The present invention is directed to new compositions of matter comprising the reaction products of a carboxylic acid and a urea having the formula: where R1, R2, R3 and R4 are...
03/23/2004
6670393Carbamate-based cationic lipids
The present invention provides novel carbamate-based cationic lipids of the general structure: ##STR1## or a salt, or solvate, or enantiomers thereof, wherein (a) R1 is a lipophilic moiety; (b) R2 is a positively charged moiety; ...
12/30/2003
6635621Cysteine protease inhibitors
This invention relates to derivatives of alpha-amino acid amides, to pharmaceutical compositions containing such compounds, and to their use in medicine as inhibitors of cysteine proteases, particularly the cathepsins. A compound of formula (I) is describ...
10/21/2003
6569411Serine carbonates
Serine carbonates of formula I are precursors for organoleptic compounds, masking agents and antimicrobial agents. Further they are alternative substrates for malodor producing enzymes. The symbols in formula I are defined in claim 1....
05/27/2003
64141581,3,4-oxadiazine derivatives and their use as pesticides
The invention relates to novel carbazate intermediates of formula (II), and to a process for their preparation, and their usefulness in the preparation of (1,3,4) oxadiazine derivatives useful as pesticides, in particular as anthelminthicides, insecticide...
07/02/2002
6395763Prodrugs of carbamate inhibitors of IMPDH
The present invention relates to novel compounds, methods of preparing these compounds, and pharmaceutical compositions comprising these compounds. These compounds are carbamate prodrugs that convert to active inhibitors of the IMPDH enzyme in vivo. The c...
05/28/2002
6395713Compositions for the delivery of negatively charged molecules
This invention features permeability enhancer molecules, and methods, to increase membrane permeability of negatively charged polymers thereby facilitating cellular uptake of such polymers....
05/28/2002
6392001Process for the production of light-stable polyisocyanates containing allophanate groups
The present invention relates to a process for the production of polyisocyanates containing allophanate groups and having aliphatically and/or cycloaliphatically bound isocyanate groups by reacting organic compounds containing urethane groups with organic...
05/21/2002
6380323Electrocoat resin compositions containing carbamate functional resins having one or more quaternary ammonium groups and at least one carbamate functional reactive additive
The invention provides a resin composition comprising (A) a polymer comprising at least 1 primary carbamate functional group and 1 or more quaternary ammonium groups, and (B) a carbamate functional reactive additive that is generated in situ during the pr...
04/30/2002
6362359One-component thermoset coating compositions
The present invention relates to compounds containing modified hydrazide groups and corresponding to formula I ##STR1## wherein R represents the residue obtained by removing the isocyanate groups from a monomeric polyisocyanate, a polyisocyanate adduct or...
03/26/2002
6339103Fungicides
The new compound, dimethy[3-(propoxycarbonylamino)propyl]ammonium O-ethylphosphonate, having fungicidal activity, its preparation, compositions comprising it and methods for its use in agriculture....
01/15/2002
6331542Protease inhibitors
The present invention provides compounds which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, and methods for treating diseases of excessive bone loss or cartilage or matrix degradation, including osteoporosis; gi...
12/18/2001
6316662Carbamate solutions with bound carbon dioxide prepared from alkanolamines
Carbamate solutions are obtainable by reacting at least one alkanolamine with carbon dioxide in, as solvent, at least one organic compound having a molecular weight of from 60 to 600 and containing at least one hydroxyl group, wherein the carbamate contai...
11/13/2001
6284777Carbohydrazide protease inhibitors
The present invention provides compounds which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, and methods for treating diseases of excessive bone loss or cartilage or matrix degradation, inducing osteoporosis; gin...
09/04/2001
6265590N଱-2-(4-nitrophenylsulfonyl)ethoxycarbonyl-amino acids
Protected amino acid derivatives of general formula (I) ##STR1## and methods for the prepatation of the derivatives are provided....
07/24/2001
6258931Deoxyhypusine reagent and peptides
The invention relates to a method and reagent for the synthesis of peptides containing deoxyhypusine, the reagent having the formula: ##STR1## wherein: Q1 and Q2 may be the same or different and are amino protective groups, and Q
07/10/2001
6258976Process for the preparation of polyamines and polyamine derivatives
Disclosed are processes for the preparation of compounds of the formula (I): H2N--(CH2)n--A--(CH2)m--NH2, or (II): H2N--(CH2)n--NH--C(.dbd.NR1)--NH--(CH2)m--NH2, wherein n and m are each independently an integer from 2 to 8; A is selected from the group ...
07/10/2001
6251382Biodegradable high molecular weight polymeric linkers and their conjugates
Polymeric compounds of the formula: (D)n --M--(R1)m (I) wherein (m) and (n) independently selected positive integers, preferably from about 1 to about 6 each; D is a residue of a biologically active moiety; M is a multifunctional l...
06/26/2001
6251939Carbamate-based cationic lipids
The present invention provides novel carbamate-based cationic lipids of the general structure: ##STR1## or a salt, or solvate, or enantiomers thereof, wherein (a) R1 is a lipophilic moiety; (b) R2 is a positively charged moiety; (c) ...
06/26/2001
6235929Tripeptide ଱-ketoamides
A novel class of tripeptide ଱-ketoamides useful for selectively inhibiting serine proteases, selectively inhibiting cysteine proteases, generally inhibiting all serine proteases, and generally inhibiting all cysteine proteases, having the formula M
05/22/2001
6221116Aminocarbamates of polyalkylphenoxyalkanols and fuel compositions containing the same
Aminocarbamates of polyalkylphenoxyalkanols having the formula: ##STR1## wherein R is a polyalkyl group having an average molecular weight in the range of about 600 to 5,000; R1 and R2 are independently hydrogen or lower alkyl having 1 to...
04/24/2001
1                
 
Sign InRegister
Username  
Password   
forgot password?